News & Perspective

Jan 18, 2019

Jan 18, 2019

ASP Scan (Weekly) for Jan 18, 2019

New CARB-X funding
VRE in Swiss hospitals
Antibiotic overprescribing in tots
Fast track for new C diff drug
Stewardship in pediatric surgery
MRSA decline in Germany
Antibiotic resistance on pig farms
Resistance genes in Bolivian river
Stewardship in English hospitals
Whiff of C diff in pets
Fecal microbiota transplant trial

Jan 11, 2019

Jan 11, 2019

ASP Scan (Weekly) for Jan 11, 2019

US XDR typhoid cases
ICU Klebsiella stewardship
Antimicrobials in European chickens
MCR-1 in Wyoming
CDC alert over Mexico infections
Highly resistant gonorrhea in the UK
Penicillin allergy testing
Antibiotics and joint replacement
MDR Shigella in Australia
Resistant-infection alert in RI

Nov 30, 2018

Nov 30, 2018

ASP Scan (Weekly) for Nov 30, 2018

Superbugs in Canadian ICUs
Probiotics and ESBL colonization
Antibiotics after rhinoplasty
Rapid flu diagnostic tests
CDC funding for AMR initiatives
VRE, MRSA co-colonization in nursing homes
UV disinfection for C diff
Fluoroquinolones and aortic rupture risk
Resistance action plan
Deaths from MDROs
Stewardship in a Japanese hospital
Stewardship study quality

Feb 10, 2017

Feb 10, 2017

News Scan for Feb 10, 2017

Saudi MERS case
Senate confirms HHS pick
Avian flu update

Jan 04, 2013

Jan 04, 2013

US flu activity continues to rise sharply

(CIDRAP News) – Influenza activity continued its sharp rise through the last week of 2012, the Centers for Disease Control and Prevention (CDC) said today.

"Reports of influenza-like-illness (ILI) are nearing what have been peak levels during moderately severe seasons," said Joe Bresee, MD, chief of epidemiology and prevention in the CDC's flu division, in a CDC statement today.

Dec 28, 2012

Dec 28, 2012

Flu markers keep climbing in US and Europe

Editor's Note: The fourth paragraph was revised on Jan 2 to clarify the current situation regarding H3N2 dominance.

(CIDRAP News) – US influenza activity continued its ascent last week, judging from the high volumes of patients seeking care for the disease at doctors' offices, while flu indicators in Europe showed a clear spike, according to the latest surveillance reports.

Jul 13, 2011

Jul 13, 2011

Study: Adjuvanted H1N1 vaccines had little effect on GBS risk

(CIDRAP News) – A five-country study from Europe indicates that the use of adjuvanted vaccines against the pandemic H1N1 influenza virus probably did not increase the risk of Guillain-Barre syndrome (GBS), but the investigators could not firmly rule out a slightly greater chance of suffering the paralytic condition.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»